AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

634.950

-11.153-1.73%

Number of Gainers:6

Number of Losers:15

Number of Flat:22

PE:- -

High:645.436

Open:638.323

Low:632.715

Close:646.103

Volume:82.34M

Turnover:107.75M

Market Cap:90.27B

Float Cap:87.07B

Loading ...

Anteotech Discloses Next Generation Battery Agreement with Airspeeder

Clinuvel Pharmaceuticals Completes Development of Proprietary Drug Delivery Device

MT Newswires Live

CitiFirst CSL SFIs Dividend Estimated Amount-CTW

Anteotech Ltd-Next Generation Battery Agreement with Airspeeder

THOMSON REUTERS

Anteotech - to Exclusively Supply Next Generation Lithium-Ion Battery Designs to Airspeeder

THOMSON REUTERS

Prescient Therapeutics Ltd-Prescient Therapeutics - Extension of Share Purchase Plan

THOMSON REUTERS

Oncosil Medical - Completes A$4.0 Mln Placement at an Issue Price of A$1.00 Per Share

THOMSON REUTERS

Oncosil Medical - Funds to Support Commercial Launch of Oncosil Device in US and Australia

THOMSON REUTERS

Oncosil Medical - Receives A$5.6 Mln Commitments from Major Institutional Investors

THOMSON REUTERS

Actinogen Medical - Confirm That Company is in Compliance with Listing Rule 3.1

THOMSON REUTERS

CSL Says Vanguard Group Raises Stake

MT Newswires Live

Australia's Immuron Hits Near 1.5-Month High on Distribution Deal in US

Biotron Ltd-Change of Share Registry

THOMSON REUTERS

Dimerix Secures AU$34 Million in Non-Dilutive Loan Facility Agreements; Shares Up 4%

MT Newswires Live

Immuron - Executes Exclusive Distribution Agreement for Proibs in the United States

THOMSON REUTERS

Dimerix Ltd - Secures A$34 Mln Non-Dilutive Funding Facility

THOMSON REUTERS

Australian Shares Rise as Miners, Banks Gain on Lower Oil, Bond Yields

ASX Penny Stocks To Watch In September 2026

Simply Wall St.

Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module

Black Box Warning on CSL's Injectafer Unlikely to Change Much

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BK7508/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":634.9499,"timestamp":1789106399475,"preClose":646.1032,"halted":0,"volume":82340846,"delay":0,"changeRate":-0.017262,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-11.15332,"latestTime":"09-11 16:00:00 AEST","open":638.3234,"high":645.43604,"low":632.7152,"amount":107748358.18,"amplitude":0.019689,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789344000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789084800000,1789106400000]],"turnoverRate":0.00323,"increases":7,"decrements":16,"flats":20,"marketCap":90265011743.75,"floatMarketCap":87070963229.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":645.43604,"amplitude":0.019689,"preClose":646.1032,"low":632.7152,"latestPrice":634.9499,"volume":82340846,"delay":0,"open":638.3234,"prevYearClose":644.3692,"prevWeekClose":666.366,"prevMonthClose":656.138,"prevQuarterClose":464.145,"fiveDayClose":666.366,"twentyDayClose":541.582,"sixtyDayClose":464.274,"secType":"PLATE","market":"AU","turnoverRate":0.00323,"marketCap":90265011743.75,"floatMarketCap":87070963229.625,"timestamp":1789106399475,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":6,"down":15,"flat":22},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665466983","title":"Anteotech Discloses Next Generation Battery Agreement with Airspeeder","url":"https://stock-news.laohu8.com/highlight/detail?id=2665466983","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665466983?lang=en_us&edition=fundamental","pubTime":"2026-09-08 09:41","pubTimestamp":1788831719,"startTime":"0","endTime":"0","summary":"BRIEF-Anteotech Discloses Next Generation Battery Agreement With AirspeederSept 8 (Reuters)-Anteotech LtdADO.AX:ANTEOTECH LTD-NEXT GENERATION BATTERY AGREEMENT WITH AIRSPEEDERANTEOTECH - SIGNS SUPPLY ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUE68J3DC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7501","BK7036","ADO.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665334536","title":"Clinuvel Pharmaceuticals Completes Development of Proprietary Drug Delivery Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2665334536","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665334536?lang=en_us&edition=fundamental","pubTime":"2026-09-08 08:43","pubTimestamp":1788828205,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals  completed the development of a proprietary single-use device for subcutaneous drug delivery aimed at both hospital use and self-administration, according to a Tuesday filing with the Australian bourse.The Zerokin device will be used to administer controlled-release formulations developed at the company's research, development and innovation center in Singapore, per the filing.Since it is intended as a Class 2 device, Zerokin will require registration for human use with the US Food and Drug Administration, and an application for CE marking under European Union regulations, the company said.It added that the global market for self-administered devices is forecast to grow to $40.5 billion by 2030 from $27.1 billion currently.Clinuvel Pharmaceuticals shares fell past 1% in recent Tuesday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","CUV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665343747","title":"CitiFirst CSL SFIs Dividend Estimated Amount-CTW","url":"https://stock-news.laohu8.com/highlight/detail?id=2665343747","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665343747?lang=en_us&edition=fundamental","pubTime":"2026-09-08 08:12","pubTimestamp":1788826355,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260908:nASXLBQ8s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nASX4xnJYB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7511","BK7501","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665916348","title":"Anteotech Ltd-Next Generation Battery Agreement with Airspeeder","url":"https://stock-news.laohu8.com/highlight/detail?id=2665916348","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665916348?lang=en_us&edition=fundamental","pubTime":"2026-09-08 07:11","pubTimestamp":1788822707,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nTUE68J3DC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7036","BK7048","BK7508","ADO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665489133","title":"Anteotech - to Exclusively Supply Next Generation Lithium-Ion Battery Designs to Airspeeder","url":"https://stock-news.laohu8.com/highlight/detail?id=2665489133","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665489133?lang=en_us&edition=fundamental","pubTime":"2026-09-08 07:11","pubTimestamp":1788822707,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nTUE68J3DC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7501","ADO.AU","BK7036","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665348989","title":"Prescient Therapeutics Ltd-Prescient Therapeutics - Extension of Share Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2665348989","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665348989?lang=en_us&edition=fundamental","pubTime":"2026-09-08 07:03","pubTimestamp":1788822214,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nTUE8B6FQW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTX.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392176","title":"Oncosil Medical - Completes A$4.0 Mln Placement at an Issue Price of A$1.00 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392176","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392176?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:12","pubTimestamp":1788765127,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44W0YS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BK7508","OSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392143","title":"Oncosil Medical - Funds to Support Commercial Launch of Oncosil Device in US and Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392143?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:12","pubTimestamp":1788765127,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44W0YS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSL.AU","BK7048","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392114","title":"Oncosil Medical - Receives A$5.6 Mln Commitments from Major Institutional Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392114","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392114?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:12","pubTimestamp":1788765127,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nFWN44W0YS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BK7508","OSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664843381","title":"Actinogen Medical - Confirm That Company is in Compliance with Listing Rule 3.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843381","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664843381?lang=en_us&edition=fundamental","pubTime":"2026-09-04 13:56","pubTimestamp":1788501366,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nFWN44V19F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","ACW.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664138693","title":"CSL Says Vanguard Group Raises Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2664138693","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664138693?lang=en_us&edition=fundamental","pubTime":"2026-09-04 11:58","pubTimestamp":1788494293,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) said Vanguard Group raised its voting power in the firm to 7.001% as of Aug. 31 from 6% previously, according to a Friday Australian bourse filing.Vanguard holds 33.5 million ordinary shares in the firm as of Aug. 31, per the filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL.AU","BK7511","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664863123","title":"Australia's Immuron Hits Near 1.5-Month High on Distribution Deal in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2664863123","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664863123?lang=en_us&edition=fundamental","pubTime":"2026-09-04 11:41","pubTimestamp":1788493288,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Immuron hits near 1.5-month high on distribution deal in US** Shares ofAustralia'sImmuronIMC.AXsoar as much as 18.9% to A$0.044,theirhighest since July 20** Stock set forits biggest gainsince August 26** The biopharmaceutical company enters into an exclusive distribution agreement for digestive health productPROIBSin the U.S. withSwedish life science firmCalmino group AB** Nearly935,000shares change hands, around 8.1x 30-day average** YTD, stock up 11.1%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nL4N44W077:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IMC.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664238884","title":"Biotron Ltd-Change of Share Registry","url":"https://stock-news.laohu8.com/highlight/detail?id=2664238884","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664238884?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:08","pubTimestamp":1788484108,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nTUE1TQ5SS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7508","BK7067","BIT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664800459","title":"Dimerix Secures AU$34 Million in Non-Dilutive Loan Facility Agreements; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664800459","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664800459?lang=en_us&edition=fundamental","pubTime":"2026-09-04 08:40","pubTimestamp":1788482421,"startTime":"0","endTime":"0","summary":"Dimerix  secured non-dilutive loan facility agreements with a syndicate of Australian and US-based lenders to access up to AU$34 million, according to a Friday Australian bourse filing.This included a previously announced initial facility agreement of AU$10 million with Skiptan, per the filing. The firm confirmed that it was funded through to completion of the Action3 phase 3 trial in DMX-200, as well as the planned phase 2 clinical trial in DMX-652.The facility carries an interest rate of 10% per year, compounding annually, the company said. The receipt of the initial 50% draw-down is anticipated by Sept. 18, and the remainder is expected to take place at the firm's discretion on or before March 31, 2027.The facility provides the flexibility for Dimerix to elect to take further commitments for up to a total of AU$50 million on or before March 31, 2027.The biopharmaceutical company's shares were up 4% in recent Friday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","DXB.AU","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664807855","title":"Immuron - Executes Exclusive Distribution Agreement for Proibs in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2664807855","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664807855?lang=en_us&edition=fundamental","pubTime":"2026-09-04 07:25","pubTimestamp":1788477919,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V0RG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMC.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664802749","title":"Dimerix Ltd - Secures A$34 Mln Non-Dilutive Funding Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2664802749","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664802749?lang=en_us&edition=fundamental","pubTime":"2026-09-04 07:17","pubTimestamp":1788477460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V175:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","DXB.AU","BK7501","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664282421","title":"Australian Shares Rise as Miners, Banks Gain on Lower Oil, Bond Yields","url":"https://stock-news.laohu8.com/highlight/detail?id=2664282421","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664282421?lang=en_us&edition=fundamental","pubTime":"2026-09-03 15:13","pubTimestamp":1788419596,"startTime":"0","endTime":"0","summary":"Australian shares rise as miners, banks gain on lower oil, bond yieldsSept 3 (Reuters)-Australian shares rebounded from a one-month low on Thursday, led by heavyweight banks, as easing oil prices and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4N44V0E2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","LU0011963245.USD","BHP.AU","LU1430597077.USD","IE00B3M56506.USD","LU0264606111.USD","LU0330918003.SGD","SG9999001143.SGD","RIO.UK","IE00BWDBJ516.SGD","LU0612318385.USD","LU1481600234.SGD","LU0505663152.USD","LU0831103253.SGD","LU0955648018.USD","BK7511","BK7095","LU0075056555.USD","STO.AU","LU0955669360.SGD","BK7007","BK7142","LU0345780950.USD","LU0971552673.USD","LU0345777659.USD","LU0161305163.EUR","LU0266512473.USD","LU1302929846.USD","BK7501","COH.AU","BK7508","LU1064927863.SGD","IE0034235071.USD","LU1130305938.SGD","LU0572939691.SGD","LU0456854461.SGD","LU1046248800.SGD","LU0612318971.USD","LU0345781412.USD","LU0171293334.USD","BK7507","LU0788109121.HKD","LU0654597011.USD","LU0572940350.SGD","LU1078025761.USD","LU0971552830.HKD","BK5111","LU0955623706.USD","BK7067","IE00BQJZX424.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664601823","title":"ASX Penny Stocks To Watch In September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664601823","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664601823?lang=en_us&edition=fundamental","pubTime":"2026-09-03 10:04","pubTimestamp":1788401097,"startTime":"0","endTime":"0","summary":"The Australian stock market is poised for a positive start today, with the ASX expected to open higher following a rebound on Wall Street. Amidst this backdrop of fluctuating indices and evolving economic trends, investors are increasingly looking at opportunities in less conventional areas. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still present valuable opportunities when they possess strong financial foundations and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-penny-stocks-to-watch-in-september-2026-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-penny-stocks-to-watch-in-september-2026-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["KSC.AU","BVS.AU","BK7503","BK7058","BK7501","BK7508","MSB.AU","BK7016","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664842977","title":"Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module","url":"https://stock-news.laohu8.com/highlight/detail?id=2664842977","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664842977?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:46","pubTimestamp":1788392770,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing ModuleSept 3 -Imricor Medical Systems, IncIMR.AX:IMRICOR MEDICAL SYSTEMS, INC-FDA ACCEPTS IMRICOR PMA MANUFACTURING MODULEIMRICOR MEDICAL SYSTEMS, - FDA ACCEPTS AND CLOSES IMRICOR'S PMA MANUFACTURING MODULEIMRICOR MEDICAL SYSTEMS, - FDA TO CONDUCT PRE-APPROVAL INSPECTION OF IMRICOR'S MANUFACTURING SITESFurther company coverage:IMR.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUEBD40TZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7503","BK7007","BK7508","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664426518","title":"Black Box Warning on CSL's Injectafer Unlikely to Change Much","url":"https://stock-news.laohu8.com/highlight/detail?id=2664426518","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664426518?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:34","pubTimestamp":1788392040,"startTime":"0","endTime":"0","summary":"2329 GMT [Dow Jones]--The addition of a black box warning to the label of CSL's Injectafer is unlikely to have a big impact, according to Citi. The Food and Drug Administration approved revised labeling for the iron replacement medicine to warn of the risk of low levels of phosphate in the blood. \"We do not think it will change much,\" says Citi. \"Generics to Injectafer have become available over the last few weeks and, per FDA, are expected to update their labels also.\" Citi has a neutral rating and A$160/share target on CSL. The stock ended Wednesday at A$173.85.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7511","BK7067","BK7508","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":114,"code":"91000000","status":"200"}]}}